Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
3.150
-0.230 (-6.80%)
Mar 31, 2025, 3:55 PM EDT - Market open
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $119.43 million as of March 31, 2025. Its market cap has increased by 12.71% in one year.
Market Cap
119.43M
Enterprise Value
116.52M
1-Year Change
12.71%
Ranking
Category
Stock Price
3.15
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $119.43M, an increase of 93.83%. That is a compound annual growth rate of 17.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 119.43M | 6.96% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.31B |
| UnitedHealth Group | 480.21B |
| Johnson & Johnson | 400.32B |
| AbbVie | 366.98B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.45B |
| AstraZeneca | 229.16B |
| Merck & Co. | 225.45B |